Generic injections are injections that have the same active ingredients, the same dosage, the same route of administration, the same dosage form, and the same indications as the original drug.

The global Generic Injection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Generic Injection in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Generic Injection market. Liquid Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Powder for Injection segment is estimated at % CAGR for the next seven-year period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Generic Injection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Generic Injection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Generic Injection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Generic Injection sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Generic Injection covered in this report include Sanofi, Fresenius, Viatris, Pfizer, Teva Pharmaceuticals, Hikma Pharmaceuticals, Novartis, Amneal Pharmaceuticals and Gland Pharma, etc.

The global Generic Injection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Sanofi

Fresenius

Viatris

Pfizer

Teva Pharmaceuticals

Hikma Pharmaceuticals

Novartis

Amneal Pharmaceuticals

Gland Pharma

Allergan

Kelun Pharmaceutical

Jiangsu HRS

Qilu Pharmaceutical

Chiatai Tianqing

Hainan Poly Pharm

Yangzijiang Pharmaceutical Industry

Shijiazhuang Pharma Group

Scope of Generic Injection - Market Report

Report Metric	Details
Report Name	Generic Injection - Market
CAGR	5%
Global Generic Injection market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Generic Injection market, Segment by Type:	Liquid Injection Powder for Injection
Global Generic Injection market, by Application	Hospital Clinic Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Generic Injection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What are the Application segmentation covered in the Generic Injection - Market report?

Ans: The Applications covered in the Generic Injection - Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Generic Injection - Market report?

Ans: The Types covered in the Generic Injection - Market report are Liquid Injection, Powder for Injection

1 Market Overview of Generic Injection

1.1 Generic Injection Market Overview

1.1.1 Generic Injection Product Scope

1.1.2 Generic Injection Market Status and Outlook

1.2 Global Generic Injection Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Generic Injection Market Size by Region (2018-2029)

1.4 Global Generic Injection Historic Market Size by Region (2018-2023)

1.5 Global Generic Injection Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Generic Injection Market Size (2018-2029)

1.6.1 North America Generic Injection Market Size (2018-2029)

1.6.2 Europe Generic Injection Market Size (2018-2029)

1.6.3 Asia-Pacific Generic Injection Market Size (2018-2029)

1.6.4 Latin America Generic Injection Market Size (2018-2029)

1.6.5 Middle East & Africa Generic Injection Market Size (2018-2029)

2 Generic Injection Market by Type

2.1 Introduction

2.1.1 Liquid Injection

2.1.2 Powder for Injection

2.2 Global Generic Injection Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Generic Injection Historic Market Size by Type (2018-2023)

2.2.2 Global Generic Injection Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Generic Injection Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Generic Injection Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Generic Injection Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Generic Injection Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Generic Injection Revenue Breakdown by Type (2018-2029)

3 Generic Injection Market Overview by Application

3.1 Introduction

3.1.1 Hospital

3.1.2 Clinic

3.1.3 Others

3.2 Global Generic Injection Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Generic Injection Historic Market Size by Application (2018-2023)

3.2.2 Global Generic Injection Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Generic Injection Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Generic Injection Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Generic Injection Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Generic Injection Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Generic Injection Revenue Breakdown by Application (2018-2029)

4 Generic Injection Competition Analysis by Players

4.1 Global Generic Injection Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Generic Injection as of 2022)

4.3 Date of Key Players Enter into Generic Injection Market

4.4 Global Top Players Generic Injection Headquarters and Area Served

4.5 Key Players Generic Injection Product Solution and Service

4.6 Competitive Status

4.6.1 Generic Injection Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Sanofi

5.1.1 Sanofi Profile

5.1.2 Sanofi Main Business

5.1.3 Sanofi Generic Injection Products, Services and Solutions

5.1.4 Sanofi Generic Injection Revenue (US$ Million) & (2018-2023)

5.1.5 Sanofi Recent Developments

5.2 Fresenius

5.2.1 Fresenius Profile

5.2.2 Fresenius Main Business

5.2.3 Fresenius Generic Injection Products, Services and Solutions

5.2.4 Fresenius Generic Injection Revenue (US$ Million) & (2018-2023)

5.2.5 Fresenius Recent Developments

5.3 Viatris

5.3.1 Viatris Profile

5.3.2 Viatris Main Business

5.3.3 Viatris Generic Injection Products, Services and Solutions

5.3.4 Viatris Generic Injection Revenue (US$ Million) & (2018-2023)

5.3.5 Pfizer Recent Developments

5.4 Pfizer

5.4.1 Pfizer Profile

5.4.2 Pfizer Main Business

5.4.3 Pfizer Generic Injection Products, Services and Solutions

5.4.4 Pfizer Generic Injection Revenue (US$ Million) & (2018-2023)

5.4.5 Pfizer Recent Developments

5.5 Teva Pharmaceuticals

5.5.1 Teva Pharmaceuticals Profile

5.5.2 Teva Pharmaceuticals Main Business

5.5.3 Teva Pharmaceuticals Generic Injection Products, Services and Solutions

5.5.4 Teva Pharmaceuticals Generic Injection Revenue (US$ Million) & (2018-2023)

5.5.5 Teva Pharmaceuticals Recent Developments

5.6 Hikma Pharmaceuticals

5.6.1 Hikma Pharmaceuticals Profile

5.6.2 Hikma Pharmaceuticals Main Business

5.6.3 Hikma Pharmaceuticals Generic Injection Products, Services and Solutions

5.6.4 Hikma Pharmaceuticals Generic Injection Revenue (US$ Million) & (2018-2023)

5.6.5 Hikma Pharmaceuticals Recent Developments

5.7 Novartis

5.7.1 Novartis Profile

5.7.2 Novartis Main Business

5.7.3 Novartis Generic Injection Products, Services and Solutions

5.7.4 Novartis Generic Injection Revenue (US$ Million) & (2018-2023)

5.7.5 Novartis Recent Developments

5.8 Amneal Pharmaceuticals

5.8.1 Amneal Pharmaceuticals Profile

5.8.2 Amneal Pharmaceuticals Main Business

5.8.3 Amneal Pharmaceuticals Generic Injection Products, Services and Solutions

5.8.4 Amneal Pharmaceuticals Generic Injection Revenue (US$ Million) & (2018-2023)

5.8.5 Amneal Pharmaceuticals Recent Developments

5.9 Gland Pharma

5.9.1 Gland Pharma Profile

5.9.2 Gland Pharma Main Business

5.9.3 Gland Pharma Generic Injection Products, Services and Solutions

5.9.4 Gland Pharma Generic Injection Revenue (US$ Million) & (2018-2023)

5.9.5 Gland Pharma Recent Developments

5.10 Allergan

5.10.1 Allergan Profile

5.10.2 Allergan Main Business

5.10.3 Allergan Generic Injection Products, Services and Solutions

5.10.4 Allergan Generic Injection Revenue (US$ Million) & (2018-2023)

5.10.5 Allergan Recent Developments

5.11 Kelun Pharmaceutical

5.11.1 Kelun Pharmaceutical Profile

5.11.2 Kelun Pharmaceutical Main Business

5.11.3 Kelun Pharmaceutical Generic Injection Products, Services and Solutions

5.11.4 Kelun Pharmaceutical Generic Injection Revenue (US$ Million) & (2018-2023)

5.11.5 Kelun Pharmaceutical Recent Developments

5.12 Jiangsu HRS

5.12.1 Jiangsu HRS Profile

5.12.2 Jiangsu HRS Main Business

5.12.3 Jiangsu HRS Generic Injection Products, Services and Solutions

5.12.4 Jiangsu HRS Generic Injection Revenue (US$ Million) & (2018-2023)

5.12.5 Jiangsu HRS Recent Developments

5.13 Qilu Pharmaceutical

5.13.1 Qilu Pharmaceutical Profile

5.13.2 Qilu Pharmaceutical Main Business

5.13.3 Qilu Pharmaceutical Generic Injection Products, Services and Solutions

5.13.4 Qilu Pharmaceutical Generic Injection Revenue (US$ Million) & (2018-2023)

5.13.5 Qilu Pharmaceutical Recent Developments

5.14 Chiatai Tianqing

5.14.1 Chiatai Tianqing Profile

5.14.2 Chiatai Tianqing Main Business

5.14.3 Chiatai Tianqing Generic Injection Products, Services and Solutions

5.14.4 Chiatai Tianqing Generic Injection Revenue (US$ Million) & (2018-2023)

5.14.5 Chiatai Tianqing Recent Developments

5.15 Hainan Poly Pharm

5.15.1 Hainan Poly Pharm Profile

5.15.2 Hainan Poly Pharm Main Business

5.15.3 Hainan Poly Pharm Generic Injection Products, Services and Solutions

5.15.4 Hainan Poly Pharm Generic Injection Revenue (US$ Million) & (2018-2023)

5.15.5 Hainan Poly Pharm Recent Developments

5.16 Yangzijiang Pharmaceutical Industry

5.16.1 Yangzijiang Pharmaceutical Industry Profile

5.16.2 Yangzijiang Pharmaceutical Industry Main Business

5.16.3 Yangzijiang Pharmaceutical Industry Generic Injection Products, Services and Solutions

5.16.4 Yangzijiang Pharmaceutical Industry Generic Injection Revenue (US$ Million) & (2018-2023)

5.16.5 Yangzijiang Pharmaceutical Industry Recent Developments

5.17 Shijiazhuang Pharma Group

5.17.1 Shijiazhuang Pharma Group Profile

5.17.2 Shijiazhuang Pharma Group Main Business

5.17.3 Shijiazhuang Pharma Group Generic Injection Products, Services and Solutions

5.17.4 Shijiazhuang Pharma Group Generic Injection Revenue (US$ Million) & (2018-2023)

5.17.5 Shijiazhuang Pharma Group Recent Developments

6 North America

6.1 North America Generic Injection Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Generic Injection Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Generic Injection Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Generic Injection Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Generic Injection Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Generic Injection Market Dynamics

11.1 Generic Injection Industry Trends

11.2 Generic Injection Market Drivers

11.3 Generic Injection Market Challenges

11.4 Generic Injection Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Hikma Pharmaceuticals

Novartis

Amneal Pharmaceuticals

Yangzijiang Pharmaceutical Industry

Shijiazhuang Pharma Group

List of Tables

Table 1. Global Market Generic Injection Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Generic Injection Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Generic Injection Market Size Share by Region (2018-2023)

Table 4. Global Generic Injection Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Generic Injection Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Generic Injection Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Generic Injection Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Generic Injection Revenue Market Share by Type (2018-2023)

Table 9. Global Generic Injection Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Generic Injection Revenue Market Share by Type (2024-2029)

Table 11. North America Generic Injection Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Generic Injection Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Generic Injection Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Generic Injection Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Generic Injection Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Generic Injection Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Generic Injection Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Generic Injection Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Generic Injection Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Generic Injection Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Generic Injection Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Generic Injection Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Generic Injection Revenue Market Share by Application (2018-2023)

Table 24. Global Generic Injection Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Generic Injection Revenue Market Share by Application (2024-2029)

Table 26. North America Generic Injection Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Generic Injection Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Generic Injection Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Generic Injection Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Generic Injection Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Generic Injection Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Generic Injection Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Generic Injection Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Generic Injection Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Generic Injection Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Generic Injection Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Generic Injection Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Generic Injection as of 2022)

Table 39. Date of Key Players Enter into Generic Injection Market

Table 40. Global Generic Injection Key Players Headquarters and Area Served

Table 41. Generic Injection Product Solution and Service

Table 42. Global Generic Injection Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Sanofi Basic Information List

Table 45. Sanofi Description and Business Overview

Table 46. Sanofi Generic Injection Products, Services and Solutions

Table 47. Revenue (US$ Million) in Generic Injection Business of Sanofi (2018-2023)

Table 48. Sanofi Recent Developments

Table 49. Fresenius Basic Information List

Table 50. Fresenius Description and Business Overview

Table 51. Fresenius Generic Injection Products, Services and Solutions

Table 52. Revenue (US$ Million) in Generic Injection Business of Fresenius (2018-2023)

Table 53. Fresenius Recent Developments

Table 54. Viatris Basic Information List

Table 55. Viatris Description and Business Overview

Table 56. Viatris Generic Injection Products, Services and Solutions

Table 57. Revenue (US$ Million) in Generic Injection Business of Viatris (2018-2023)

Table 58. Viatris Recent Developments

Table 59. Pfizer Basic Information List

Table 60. Pfizer Description and Business Overview

Table 61. Pfizer Generic Injection Products, Services and Solutions

Table 62. Revenue (US$ Million) in Generic Injection Business of Pfizer (2018-2023)

Table 63. Pfizer Recent Developments

Table 64. Teva Pharmaceuticals Basic Information List

Table 65. Teva Pharmaceuticals Description and Business Overview

Table 66. Teva Pharmaceuticals Generic Injection Products, Services and Solutions

Table 67. Revenue (US$ Million) in Generic Injection Business of Teva Pharmaceuticals (2018-2023)

Table 68. Teva Pharmaceuticals Recent Developments

Table 69. Hikma Pharmaceuticals Basic Information List

Table 70. Hikma Pharmaceuticals Description and Business Overview

Table 71. Hikma Pharmaceuticals Generic Injection Products, Services and Solutions

Table 72. Revenue (US$ Million) in Generic Injection Business of Hikma Pharmaceuticals (2018-2023)

Table 73. Hikma Pharmaceuticals Recent Developments

Table 74. Novartis Basic Information List

Table 75. Novartis Description and Business Overview

Table 76. Novartis Generic Injection Products, Services and Solutions

Table 77. Revenue (US$ Million) in Generic Injection Business of Novartis (2018-2023)

Table 78. Novartis Recent Developments

Table 79. Amneal Pharmaceuticals Basic Information List

Table 80. Amneal Pharmaceuticals Description and Business Overview

Table 81. Amneal Pharmaceuticals Generic Injection Products, Services and Solutions

Table 82. Revenue (US$ Million) in Generic Injection Business of Amneal Pharmaceuticals (2018-2023)

Table 83. Amneal Pharmaceuticals Recent Developments

Table 84. Gland Pharma Basic Information List

Table 85. Gland Pharma Description and Business Overview

Table 86. Gland Pharma Generic Injection Products, Services and Solutions

Table 87. Revenue (US$ Million) in Generic Injection Business of Gland Pharma (2018-2023)

Table 88. Gland Pharma Recent Developments

Table 89. Allergan Basic Information List

Table 90. Allergan Description and Business Overview

Table 91. Allergan Generic Injection Products, Services and Solutions

Table 92. Revenue (US$ Million) in Generic Injection Business of Allergan (2018-2023)

Table 93. Allergan Recent Developments

Table 94. Kelun Pharmaceutical Basic Information List

Table 95. Kelun Pharmaceutical Description and Business Overview

Table 96. Kelun Pharmaceutical Generic Injection Products, Services and Solutions

Table 97. Revenue (US$ Million) in Generic Injection Business of Kelun Pharmaceutical (2018-2023)

Table 98. Kelun Pharmaceutical Recent Developments

Table 99. Jiangsu HRS Basic Information List

Table 100. Jiangsu HRS Description and Business Overview

Table 101. Jiangsu HRS Generic Injection Products, Services and Solutions

Table 102. Revenue (US$ Million) in Generic Injection Business of Jiangsu HRS (2018-2023)

Table 103. Jiangsu HRS Recent Developments

Table 104. Qilu Pharmaceutical Basic Information List

Table 105. Qilu Pharmaceutical Description and Business Overview

Table 106. Qilu Pharmaceutical Generic Injection Products, Services and Solutions

Table 107. Revenue (US$ Million) in Generic Injection Business of Qilu Pharmaceutical (2018-2023)

Table 108. Qilu Pharmaceutical Recent Developments

Table 109. Chiatai Tianqing Basic Information List

Table 110. Chiatai Tianqing Description and Business Overview

Table 111. Chiatai Tianqing Generic Injection Products, Services and Solutions

Table 112. Revenue (US$ Million) in Generic Injection Business of Chiatai Tianqing (2018-2023)

Table 113. Chiatai Tianqing Recent Developments

Table 114. Hainan Poly Pharm Basic Information List

Table 115. Hainan Poly Pharm Description and Business Overview

Table 116. Hainan Poly Pharm Generic Injection Products, Services and Solutions

Table 117. Revenue (US$ Million) in Generic Injection Business of Hainan Poly Pharm (2018-2023)

Table 118. Hainan Poly Pharm Recent Developments

Table 119. Yangzijiang Pharmaceutical Industry Basic Information List

Table 120. Yangzijiang Pharmaceutical Industry Description and Business Overview

Table 121. Yangzijiang Pharmaceutical Industry Generic Injection Products, Services and Solutions

Table 122. Revenue (US$ Million) in Generic Injection Business of Yangzijiang Pharmaceutical Industry (2018-2023)

Table 123. Yangzijiang Pharmaceutical Industry Recent Developments

Table 124. Shijiazhuang Pharma Group Basic Information List

Table 125. Shijiazhuang Pharma Group Description and Business Overview

Table 126. Shijiazhuang Pharma Group Generic Injection Products, Services and Solutions

Table 127. Revenue (US$ Million) in Generic Injection Business of Shijiazhuang Pharma Group (2018-2023)

Table 128. Shijiazhuang Pharma Group Recent Developments

Table 129. North America Generic Injection Market Size by Country (2018-2023) & (US$ Million)

Table 130. North America Generic Injection Market Size by Country (2024-2029) & (US$ Million)

Table 131. Europe Generic Injection Market Size by Country (2018-2023) & (US$ Million)

Table 132. Europe Generic Injection Market Size by Country (2024-2029) & (US$ Million)

Table 133. Asia-Pacific Generic Injection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 134. Asia-Pacific Generic Injection Market Size by Region (2018-2023) & (US$ Million)

Table 135. Asia-Pacific Generic Injection Market Size by Region (2024-2029) & (US$ Million)

Table 136. Asia-Pacific Generic Injection Market Share by Region (2018-2023)

Table 137. Asia-Pacific Generic Injection Market Share by Region (2024-2029)

Table 138. Latin America Generic Injection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 139. Latin America Generic Injection Market Size by Country (2018-2023) & (US$ Million)

Table 140. Latin America Generic Injection Market Size by Country (2024-2029) & (US$ Million)

Table 141. Middle East & Africa Generic Injection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 142. Middle East & Africa Generic Injection Market Size by Country (2018-2023) & (US$ Million)

Table 143. Middle East & Africa Generic Injection Market Size by Country (2024-2029) & (US$ Million)

Table 144. Generic Injection Market Trends

Table 145. Generic Injection Market Drivers

Table 146. Generic Injection Market Challenges

Table 147. Generic Injection Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Generic Injection Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Generic Injection Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Generic Injection Market Share by Regions: 2022 VS 2029

Figure 4. Global Generic Injection Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Generic Injection Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Generic Injection Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Generic Injection Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Generic Injection Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Generic Injection Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Liquid Injection

Figure 11. Global Liquid Injection Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Powder for Injection

Figure 13. Global Powder for Injection Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Global Generic Injection Market Size Share by Type: 2022 & 2029

Figure 15. North America Generic Injection Revenue Market Share by Type (2018-2029)

Figure 16. Europe Generic Injection Revenue Market Share by Type (2018-2029)

Figure 17. Asia-Pacific Generic Injection Revenue Market Share by Type (2018-2029)

Figure 18. Latin America Generic Injection Revenue Market Share by Type (2018-2029)

Figure 19. Middle East and Africa Generic Injection Revenue Market Share by Type (2018-2029)

Figure 20. Hospital Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 21. Clinic Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 22. Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 23. Global Generic Injection Market Size Share by Application: 2022 & 2029

Figure 24. North America Generic Injection Revenue Market Share by Application (2018-2029)

Figure 25. Europe Generic Injection Revenue Market Share by Application (2018-2029)

Figure 26. Asia-Pacific Generic Injection Revenue Market Share by Application (2018-2029)

Figure 27. Latin America Generic Injection Revenue Market Share by Application (2018-2029)

Figure 28. Middle East and Africa Generic Injection Revenue Market Share by Application (2018-2029)

Figure 29. Generic Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 30. Global Top 5 and Top 10 Players Generic Injection Market Share in 2022

Figure 31. North America Generic Injection Market Share by Country (2018-2029)

Figure 32. U.S. Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 33. Canada Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 34. Germany Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 35. France Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 36. U.K. Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 37. Italy Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 38. Russia Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 39. Nordic Countries Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 40. Asia-Pacific Generic Injection Market Share by Region (2018-2029)

Figure 41. China Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 42. Japan Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 43. South Korea Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 44. Southeast Asia Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 45. India Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 46. Australia Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 47. Latin America Generic Injection Market Share by Country (2018-2029)

Figure 48. Mexico Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 49. Brazil Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 50. Middle East & Africa Generic Injection Market Share by Country (2018-2029)

Figure 51. Turkey Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 52. Saudi Arabia Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 53. UAE Generic Injection Market Size (2018-2029) & (US$ Million)

Figure 54. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions